PBM — Psyence Biomedical Balance Sheet
0.000.00%
Last trade - 00:00- $8.21m
- $9.73m
Annual balance sheet for Psyence Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.648 | 0.129 |
| Net Total Receivables | — | 0.829 |
| Prepaid Expenses | ||
| Total Current Assets | 0.973 | 1.21 |
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 256 | 259 |
| Payable / Accrued | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.069 | 14.3 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 19.6 | 14.3 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 237 | 245 |
| Total Liabilities & Shareholders' Equity | 256 | 259 |
| Total Common Shares Outstanding |